There is growing interest in the use of mesenchymal stem cells (MSCs) to improve the outcome of organ transplantation. The immunogenicity of MSCs is, however, unclear and is important for the efficacy of MSC therapy and for potential sensitization against donor antigens. We investigated the susceptibility of autologous and allogeneic MSCs for lysis by CD8 + T-lymphocytes and NK cells in a kidney transplant setting. MSCs were derived from adipose tissue of human kidney donors and were CD90 + , CD105 + , CD166 + , and HLA class I + . They showed differentiation ability and immunosuppressive capacity. Lysis of MSCs by peripheral blood mononuclear cells (PBMCs), FACS-sorted CD8 + T cells, and NK cells was measured by europium release assay. Allogeneic MSCs were susceptible for lysis by cytotoxic CD8 + T cells and NK cells, while autologous MSCs were lysed by NK cells only. NK cell-mediated lysis was inversely correlated with the expression of HLA class I on MSCs. Lysis of autologous MSCs was not dependent on culturing of MSCs in FBS, and MSCs in suspension as well as adherent to plastic were lysed by NK cells. Pretransplant recipient PBMCs did not lyse donor MSCs, but PBMCs isolated 3, 6, and 12 months after transplantation showed increasing lysing ability. After 12 months, CD8 + T-cell-mediated lysis of donor MSCs persisted, indicating there was no evidence for desensitization against donor MSCs. Lysis of MSCs is important to take into account when MSCs are considered for clinical application. Our results suggest that the HLA background of MSCs and timing of MSC administration are important for the efficacy of MSC therapy.
INTRODUCTION
largely mediated via soluble factors. Via these factors MSCs inhibit T-cell proliferation (1, 15) , maturation of dendritic cells, and differentiation of B lymphocytes Mesenchymal stem cells (MSCs) have beneficial regenerative and immunomodulatory properties that make (3, 11, 45) . Moreover, MSCs inhibit the formation of cytotoxic CD8 + T cells (2) and proliferation and cytotoxic them promising for use in the treatment and prevention of a variety of disorders, including graft-versus-host dis-activity of natural killer (NK) cells (38, 42, 43) . Reversely, it is less clear how immune cells affect MSCs. ease and multiple sclerosis (19, 20, 28) . Recently, interest has risen in the use of MSCs to improve the outcome of It is reported that MSCs have a low immunophenotype as they express low levels of human leukocyte antigen organ transplantation (14) . Animal models have demonstrated the ability of MSCs to prolong the survival of (HLA) class I, no HLA class II, and costimulatory molecules like CD80 and CD86, and that they therefore do skin (5), heart (9, 37) , and islets allografts (15) and to facilitate the recovery of kidney function after acute and not provoke immune responses (6, 39) . This would make MSCs transplantable across HLA barriers (29) . In con-chronic injury (30, 41) . It is therefore anticipated that MSC therapy in transplant patients may allow a reduc-trast, there is evidence that MSCs are immunogenic and can induce memory T-cell responses (4, 32) . Further-tion in the dosing of immunosuppressive drugs and thereby limit their side effects, and to aid the repair of more, it has been reported that MSCs are susceptible for lysis by NK cells (2, 34, 42) as MSCs express the activat-ischemia-reperfusion injury of the transplant (25) .
The immunomodulatory functions of MSCs are ing NK cell receptor ligands NKG2D and UL16 (35) . 1548 CROP ET AL.
Interesting in this respect is the fact that intravenously and 5. When indicated, MSCs were cultured with 50 ng/ ml interferon-γ (IFN-γ; U-CyTech biosciences, Utrecht, administered MSCs have repeatedly been demonstrated to disappear within days after infusion in immunocom-The Netherlands) for 7 days. petent mice (37) . It is not unlikely that lysis by cytotoxic Silencing of HLA Class I Expression cells is responsible for the disappearance of MSCs (4, 17). The observation of tumor formation after adminis-HLA class I expression by MSCs was modulated by small interfering RNA (siRNA). Seven µl of siRNA for tration of autologous MSCs in immunodeficient mice further strengthens this possibility (18) .
HLA class I (Ambion, Austin, TX, USA) was added to 50 µl Opti-MEM (Gibco BRL). Twelve µl of si-Port It has been demonstrated that exposure of MSCs to inflammatory conditions has an important impact on the (Ambion) was added to 50 µl Opti-MEM. siRNA and si-Port were mixed and incubated for 10 min at room immunomodulatory function of MSCs (27, 36) . In concert with the increased immunosuppressive properties of temperature and added to a six-well plate. Cell suspension in α-MEM with 15% FBS (0.5 ml) was added and MSCs, these conditions also change the immunophenotype of MSCs by upregulating the expression of HLA incubated for 3 days. Controls were treated with noncoding siRNA. molecules, costimulatory molecules, and adhesion molecules (8). This would make allogeneic MSCs potentially Flow Cytometric Characterization of MSCs more susceptible for recognition by CD8 + T cells. The immunogenicity and survival of MSCs after administra-MSCs were trypsinized, washed twice with FACS Flow (BD Biosciences, San Jose, CA, USA), and incu-tion is important for the efficacy of MSC therapy. Furthermore, in an organ transplant setting potential prim-bated with antibodies against CD90-APC (allophycocyanin), CD105-FITC (fluorescein isothiocyanate; all R&D ing by donor MSCs is of great relevance as it may induce rejection of the donor graft or perhaps desensitize Systems, Abingdon, UK), CD166-PE (phycoerythrin; BD Biosciences), HLA class I-ABC-PE, CD86-PE (Ser-against donor antigens. Therefore, in the present study we investigated the susceptibility of autologous and allo-otec), and HLA class II-DR-FITC (BD Biosciences) for 30 min. After incubation, cells were washed twice with geneic adipose tissue-derived MSCs for lysis by NK cells and CD8 + T cells. In addition, it was examined FACSFlow and flow cytometric analysis performed using an eight-color FACSCANTO-II with FACSDIVA whether the susceptibility of donor-derived MSCs for lysis by recipient cytotoxic cells changed in time after Software (BD Biosciences (12, 24) . Cultures were kept at 37°C, 5% CO 2 , and 95% humidity Adipogenic differentiation was induced by culturing confluent ASC cultures in α-MEM supplemented with and refreshed twice weekly with MSC culture medium, consisting of α-MEM (Gibco BRL) with p/s and 15% 1% p/s, 15% heat-inactivated FBS, 50 µg/ml L-ascorbic acid phosphate (Sigma-Aldrich), 500 µM 3-isobutyl-1-fetal bovine serum (FBS, Biowithaker, Verviers, Belgium). At 90% confluence, adherent cells were removed methylxanthine (IBMX, Fluka, Buchs, Switzerland), 60 µM indomethacin (Fluka), and 10 nM dexamethasone from culture flasks by incubation in 0.05% trypsin-EDTA at 37°C and cells were used for experiments de-(Sigma-Aldrich) for 21 days. Cells were then fixed in 60% isopropanol for 1 min, and incubated in filtered scribed below or frozen at −150°C until further use. MSCs were used for experiments between passages 2 0.3% oil red O (Sigma-Aldrich) solution in 60% isopro-panol for 10 min to stain lipid droplets. After several 2. After 7 days, target cells were washed and living cells counted using an automatic cell counter system Casy washes with PBS the cells were photographed.
(Schärfe System, Reutlingen, Germany). In addition, Inhibition of Mixed-Lymphocyte Reactions by MSCs 100,000 target cells were used for flow cytometric analysis of HLA class I-ABC. The remaining target cells The immunosuppressive capacity of MSCs was tested in mixed-lymphocyte reactions (MLR). Responder pe-were labeled with europium-diethylenetriaminepentaacetate (DTPA) (Sigma, St. Louis, MO, USA). Autol-ripheral blood mononuclear cells (PBMCs; 5 × 10 4 ) were stimulated by 5 × 10 4 γ-irradiated (40 Gy) alloge-ogous PHA blasts were used as negative control; allogeneic PHA blasts were used as positive control. MSCs neic PBMCs in RPMI + 10% HI-FBS in round-bottom 96-well plates (Nunc, Roskilde, Denmark). MSCs were were cultured under control conditions or with 50 ng/ml IFN-γ for 7 days. added at various ratios to responder cells. On day 7, proliferation was measured by incorporation of [ 3 H]thymi-At day 7, cytotoxicity-mediated lysis assays were performed by incubating 5 × 10 3 63 Eu-labeled targets dine (0.5 µCi/well) during a 16-h incubation using a βplate reader.
with various numbers of effector cells in 96-well plates for 4 h. Effector/target (ET) ratios ranged from 40:1 to Isolation of PBMCs 1.25:1. After incubation, the plates were centrifuged and 20 µl of the supernatant was transferred to 96-well Peripheral blood samples were collected from living kidney donors and the corresponding kidney transplant plates with low background fluorescence (Fluoroimmunoplate, Nunc, Roskilde, Denmark). Subsequently, 100 recipients. Heparinized blood of kidney transplant recipients was drawn before transplantation, and 3, 6, and 12
µl enhancement solution (PerkinElmer, Groningen, The Netherlands) was added to each well. Released euro-months after kidney transplantation. PBMCs were isolated by density gradient centrifugation using Ficoll Iso-pium was measured in a time-resolved fluorometer (Victor 1420 Multilabel Counter, LKB-Wallac, Turku, Fin-paque (δ = 1.077, Amersham, Uppsala, Sweden) and frozen at −150°C until use. land). Fluorescence was expressed in counts per second (cps).
Living Kidney Transplant Recipient and Donor Pairs
Maximum release of europium by target cells was measured by incubation of 5 × 10 3 labeled target cells To investigate the cytotoxicity-mediated lysis of MSCs in a clinical kidney transplantation setting, non-with 1% triton (Sigma-Aldrich, Zwijndrecht, The Netherlands) for 4 h. Spontaneous release of europium by HLA-identical living kidney donor-recipient pairs were included. Recipient PBMCs isolated before transplanta-target cells was measured by incubation of labeled target cells without effector cells. Percentage leakage was then tion and 3, 6, 12, 16, 18, and 24 months after transplantation were used as effector cells, while PBMCs and calculated as: (spontaneous release/maximum release) × 100%. Mean percentage of leakage was 29 ± 9% for MSCs of the corresponding donor were used as targets in the cell-mediated lysis assays. Immunosuppressive PHA blasts, 25 ± 6% for MSCs, and 26 ± 7% for IFN-γ pretreated MSCs. Finally, the percentage of cytotoxic-therapy of kidney transplant recipients consisted of tacrolimus, mycophenolate mofetil, and low-dose steroids.
ity-mediated lysis was calculated as: % lysis = [(measured lysis − spontaneous release)/(maximum release − Cytotoxicity-Mediated Lysis by Europium spontaneous release)] × 100%.
Release Assay
Isolation of CD8 + T Cells and CD16 + 56 + NK Cells Cytotoxicity-mediated lysis of target cells was deterby FACS mined by europium release assays as described previously (7,47). In brief, for effector cells PBMCs de-PBMCs cultured with allogeneic γ-irradiated PBMCs and 200 IU/ml IL-2 for 7 days were washed twice with rived from recipients and healthy kidney donors were stimulated with allogeneic γ-irradiated PBMCs and 200 PBS with 1% heat-inactivated FBS and stained with antibodies against CD3-PE, CD4-FITC, CD8-PE-Cy7, IU/ml IL-2 (proleukin; Chiron BV, Amsterdam, The Netherlands) in round-bottom 96-well plates for 7 days CD56-APC, CD19-Amcyan, 7AAD-viaprobe (all BD Biosciences), and CD16-APC (Serotec) at room temper-at 37°C. Phytohemagglutinin (PHA) blasts and MSCs were used as target cells. To obtain PHA blasts, PBMCs ature and protected from light for 30 min. Subsequently, cells were sorted using a FACS ARIA-II with FACS were stimulated with 200 IU/ml recombinant IL-2 and 2 µg/mL PHA in 24-well plates (Greiner Bio-one, Alphen DIVA Software (BD Biosciences). The lymphocytes were gated for CD3. The CD3 + cells were then gated for a/d Rijn, The Netherlands) for 7 days at 37°C. At day 3 and 6, cell cultures were split in two and refreshed with CD8 to obtain CD8 + T cells. The CD3 − cells were gated for CD16/56 to obtain NK cells. Purity of sorted CD8 + culture medium containing 200 IU/ml recombinant IL-T cells and CD16 + 56 + NK cells was ≥ 98%. PBMCs of lysis of PHA blasts. Over 95% of MSCs and PHA blasts generated from PBMCs of healthy kidney donors ex-healthy kidney donors used as effector cells consisted of 23 ± 10% (mean ± SD) CD8 + T cells and 22 ± 11% NK pressed HLA class I-ABC. Cytotoxic effector cells were generated from PBMCs of healthy kidney donors by cul-cells. Effector cells derived from PBMCs of kidney recipients (12 months after transplantation) contained 22 ture in the presence of γ-irradiated allogeneic PBMCs and 200 IU/ml IL-2 for 1 week. Effector cells lysed allo-± 9% CD8 + T cells and 16 ± 8% NK cells.
geneic PHA blasts in a dose-dependent manner ( Fig.  Microarray Analysis  2A) . Allogeneic MSCs were lysed in a comparable fash-The expression of activating NK cell receptor ligands ion. To investigate whether lysis of allogeneic PHA on MSCs was examined by microarray analysis, accordblasts and MSCs was mediated by CD8 + T cells or NK ing to the manufacturer's description. In brief, 100 ng cells, effector cells were sorted in CD3 + /CD8 + T cells of total RNA of four MSC cultures was used to prepare and CD3 − /CD16 + 56 + NK cells. PHA blasts were lysed sense-strand biotinylated DNA according to the manuby CD8 + T cells, but not by NK cells (Fig. 2B) . MSCs, facturer's "Whole transcript sense target labeling" protoin contrast, were lysed by both CD8 + T cells and NK col (Affymetrix, Santa Clara, CA, USA). Hybridization cells (Fig. 2B ). Lysis of MSCs by allogeneic NK cells to Affymetrix Human Gene 1.0 ST Arrays (764,885 was most efficient (58% of MSCs at an ET ratio of 1: probe sets, representing 28,869 annotated genes), stain-40 vs. 41% of MSCs by allogeneic CD8 + T cells at the ing, washing, and scanning (Scanner 3000) procedures same ET ratio). The lysis of MSCs by NK cells may be were performed as described by Affymetrix (Affymerelated to the expression of activating NK cell receptor trix) and performed by Erasmus MC Center for Biomics.
ligands by MSCs ( Fig. 2C ). Probe set summarization, Array QC, and annotations of the probesets were performed using Affymetrix "Gene
Reduces NK Cell-Mediated Lysis of Allogeneic MSCs
To investigate whether the susceptibility of MSCs for Statistical Analysis cytotoxicity-mediated lysis was affected by inflamma-Distribution of the data was tested with Kolmogorovtory conditions, MSCs were cultured for 7 days with Smirnov test for normality. Parametric data were ana-IFN-γ. Culturing of MSCs with IFN-γ increased the lyzed using two-way ANOVA for repeated measures mean fluorescence intensity (MFI) of HLA-ABC 4.7with Bonferroni posttests, while nonparametric data fold (Fig. 3A) . The susceptibility of allogeneic MSCs were analyzed by Kruskal-Wallis. Parametric data are for NK cell-mediated lysis was decreased by IFN-γ expressed as mean ± SD, while nonparametric data are treatment ( Fig. 3B ), while lysis of MSCs by CD8 + T expressed as median (25th-75th percentile, interquartile cells was increased ( Fig. 3C ). range). Statistical significance was defined as p < 0.05 (two-tailed).
Autologous MSCs Are Susceptible for Cytotoxicity-Mediated Lysis by NK Cells RESULTS
After demonstrating that MSCs were effectively Characterization of MSCs lysed by allogeneic CD8 + T cells and NK cells, we ques-The cells isolated from perirenal adipose tissue tioned whether MSCs were susceptible for lysis by aushowed an immunophenotype typical for MSCs with tologous cytotoxic cells. Cytotoxic effector cells, isopositive expression of CD90, CD105, CD166, HLA lated from kidney donors, were not capable of lysing class I-ABC, and very low expression of CD86 and autologous PHA blasts, isolated from the same kidney HLA class II-DR (Fig. 1A) , as described earlier (12) .
donors, at any ET ratio, but lysed 27 ± 20% of autolo-They were adherent with a spindle-shaped morphology gous MSCs at an ET ratio of 40:1 (Fig. 4A ). FACS puri-( Fig. 1B) and showed the capacity to differentiate into fication of CD8 + T cells and NK cells showed that lysis the osteogenic lineage, as demonstrated by von Kossa of autologous MSCs was the result of NK cell cytotoxic staining for calcified nodules (Fig. 1C ) and the adipoactivity (Fig. 4B ). genic lineage, as demonstrated by Oil red O staining for
To exclude the possibility that the observed lysis of lipid vesicles (Fig. 1D) . Typically for MSCs, they autologous MSCs was the result of recognition of boshowed the capacity to dose-dependently inhibit the provine proteins by NK cells due to culture of MSCs in liferation of allo-activated PBMCs (Fig. 1E) .
FBS, MSCs were isolated from adipose tissue and cul-Allogeneic MSCs Are Susceptible for Cytotoxicitytures established and maintained in either medium con-Mediated Lysis by CD8 + T Cells and NK Cells taining 15% FBS or 15% human serum (HuS). Autologous effector cells lysed MSCs cultured in FBS as To investigate the susceptibility of MSCs for lysis by cytotoxic immune cells, lysis of MSCs was compared to efficiently as MSCs cultured in HuS (52 ± 25% vs. 49 ± 20% lysis at an ET ratio of 40:1) ( Fig. 4C) . These results The fate of MSCs after infusion is currently unclear. One possibility is that MSCs home to sites of injury indicate that culturing of MSCs in FBS is not the cause of their susceptibility to cytotoxicity-mediated lysis.
where they adhere to local stroma or epithelial cell layers. To determine whether adherent MSCs would remain To examine the role of HLA class I on NK cell lysis of autologous MSCs, HLA expression was increased by susceptible for lysis by autologous NK cells, MSCs were seeded in six-well plates and purified NK cells added. treatment of MSCs with IFN-γ for 7 days or decreased by culturing MSCs with siRNA for HLA class I for 3
Autologous NK cells showed potent capacity to lyse adherent MSCs (92% lysis at an ET ratio) ( Fig. 4G ). IFN-γ days. Culturing MSCs with siRNA for HLA class I strongly reduced HLA class I-ABC expression on MSCs treatment strongly reduced the susceptibility of adherent MSCs for lysis by autologous NK cells to 52% lysis. and only 13% of MSCs showed positive expression, while the MFI reduced 2.8-fold (Fig. 4D) .
Kidney Donor-Derived MSCs Are Lysed by Recipient In agreement with the findings with allogeneic MSCs, Cytotoxic Immune Cells the lysis of autologous MSCs by NK cells was decreased after IFN-γ treatment of MSCs to 50 ± 2% (ET ratio of The immunogenicity and survival of MSCs is an important issue for their application in organ transplanta-40:1) ( Fig. 4E ). MSCs cultured with siRNA for HLA class I showed significantly increased susceptibility of MSCs tion. As we found that MSCs are susceptible for CD8 + T-cell-and NK cell-mediated lysis, we wanted to exam-for autologous NK cell-mediated lysis (Fig. 4F) .
ine this in a kidney transplant setting using donor MSCs at an ET ratio of 40:1). Recipient cytotoxic cells isolated 3, 6, and 12 months after transplantation showed in-and kidney recipient immune cells isolated at various time points after kidney transplantation. Cytotoxic ef-creasing capacity to lyse MSCs in time after transplantation ( Fig. 5A ). Lysis of donor MSCs 12 months after fector cells of recipients isolated before transplantation showed poor capacity to lyse donor MSCs (5 ± 5% lysis transplantation was for 33% (9-57%) dependent on CD8 + T-cell-mediated lysis while the CD8 + T-cell-depleted cell fraction was responsible for 55% (46-68%) of MSC lysis (Fig. 5B ). This indicates that the recovered lysis of donor MSCs after transplantation is for a major part dependent on NK cell cytotoxicity. Finally, we examined whether there was evidence for the development of hypo-or hyperresponsiveness (sensitization) of kidney transplant recipients against donor MSC after transplantation by looking at the capacity of recipient CD8 + T cells to lyse donor MSCs. As we found that non-CD8 + T-cell-mediated lysis of donor MSCs was recovered 12 months after transplantation, we examined whether the balance between CD8 + T-cell-mediated and non-CD8 + T-cell-mediated lysis of donor MSC was shifted more than 12 months after transplantation compared to nontransplant healthy kidney donors. CD8 + Tcell-mediated lysis of donor MSCs remained well below the lysis of donor MSCs by CD8 + T-cell-depleted cells in three recipients that were 16, 18, and 24 months after transplantation (Fig. 5C ). These results suggest that there is no evidence for hypo-or hyperresponsiveness against donor MSCs long after kidney transplantation.
DISCUSSION
In an increasing number of clinical trials the use of MSCs for immune therapy is studied. Trials investigating the use of MSCs in organ transplantation have recently initiated (25) . Although the use of autologous MSCs may be preferable to avoid recognition of MSCs by the immune system, the use of "off-the-shelf" allogeneic MSCs is more practical. The immunogenicity and survival of autologous and allogeneic MSCs are, however, unknown and are important for the efficacy of clinical trials. In particular, they may have implications in an organ transplant setting where cross-reactivity between MSCs and the organ transplant may induce allograft rejection. In the present study we investigated the susceptibility of autologous and allogeneic MSCs cultured under control and inflammatory conditions for lysis by cytotoxic CD8 + T cells and NK cells. Subse- for lysis by cytotoxic immune cells (38, 39) . Others re-remains remarkable. We previously demonstrated that MSCs of donor origin can be isolated from heart biop-ported that MSCs are susceptible for cytotoxicity-mediated lysis, especially by NK cells (44, 49) . In our hands, sies up to 6 years after heart transplantation in human (23) . These heart transplant patients were obviously un-allogeneic adipose tissue-derived MSCs were highly susceptible for cytotoxicity-mediated lysis, at a rate der immunosuppression, suggesting that the lysis of MSCs may be preventable with immunosuppressive drugs. comparable to allogeneic PHA blasts. Whereas allogeneic PHA blasts were lysed by CD8 + T cells only, allo-It has been reported previously that exposure of MSCs to inflammatory conditions affects immunophe-geneic MSCs were lysed by CD8 + T cells and NK cells. This difference may lie in expression of activating NK notype and enhances the immunosuppressive function of MSCs (13, 22, 27, 31) . This is particularly relevant when cell receptor ligands on MSCs and PHA blasts of which several are found on MSCs (35, 44) . Autologous MSC MSCs are used as clinical immune therapy. Proinflammatory cytokines, such as IFN-γ, increase the expression were not lysed by CD8 + T cells, but were susceptible for lysis by NK cells. Expression levels of HLA class I of HLA class I and II subtypes on MSCs. Pretreatment of autologous and allogeneic MSCs with IFN-γ made molecules modulated the susceptibility of MSCs for NK cell lysis, as downregulation of HLA class I increased them less susceptible for NK-mediated lysis, whereas it increased CD8 + T-cell-mediated lysis of allogeneic lysis of MSCs by NK cells, whereas upregulation of HLA class I by IFN-γ was associated with protection of MSCs as a result of elevated HLA class I expression. In line with the results obtained from healthy individuals, MSCs. We ruled out the possibility that lysis of MSCs was the result of recognition of bovine antigens due to we found that kidney transplant recipient-derived cytotoxic CD8 + T cells and NK cells were capable of lysing culture of MSCs in FBS by establishing and maintaining MSC cultures in medium with human serum. Culturing donor-derived MSCs. Recipient cytotoxic cells isolated with increasing time after transplantation were increas-in human serum had no effect on lysis of MSCs.
The fate of MSCs after intravenous infusion is not ingly efficient in lysing MSCs compared to recipient cells isolated before transplantation. The lack of lysis of yet clear. One possibility is that MSCs home to specific tissue sites or to sites of injury, and adhere to the stroma MSCs by recipient immune cells isolated prior to transplantation could reflect the poor renal function and gen-or epithelial cell layers at these sites. To find out whether homing would protect MSCs from lysis by NK eral health of the patients, while the increasingly efficient lysis of MSCs after transplantation may be the cells, we added autologous NK cells to adherent MSC monolayers. Under these conditions, MSCs remained result of recovery of the renal function or improvement of the recipient's immune system and tapering of immu-susceptible for lysis by NK cells, suggesting that homed MSCs can still be cleared by NK cells. More research is nosuppressive drugs after transplantation. We also found that CD8 + T-cell-mediated lysis of donor MSC more needed to investigate the distribution and integration of the engrafted cells into host tissues. Labeling MSCs with than a year after transplantation remained well below the lysing efficiency of NK cells, similar to that found micron-sized iron oxide particles (MPIOs) is a promising tool for in vivo cell tracking and evaluation of cell-in healthy kidney donors, indicating that hyperresponsiveness against donor MSCs may not occur. based therapies, as reported previously (33).
Our finding that both autologous and allogeneic The susceptibility of MSCs for lysis by cells of the innate and adaptive immune system may be of important MSCs are susceptible for lysis by cytotoxic cells may explain why MSCs seem to disappear shortly after infu-relevance for the efficacy, but also for the safety of MSC therapy. If MSCs are removed rapidly after infusion, this sion (14, 17, 46) . Nevertheless, lysis of autologous MSCs 
